Cardiac Resynchronisation Therapy in Heart Failure

Cardiac resynchronisation therapy--new treatment for heart failure.

CLINICAL REVIEW Cardiac resynchronisation therapy for chronic heart failure

Chronic heart failure is common, affecting about 900 000 people in theUnited Kingdom andwith a prevalence of about 6-10% in people aged over 65 years; despite modern drug treatment, it carries a high morbidity and a 10% annual mortality. About a third of patients with chronic heart failure have a left ventricular ejection fraction ≤35%, up to 40% of whom are at risk of worse outcomes and more s...

Cardiac resynchronisation (biventricular pacing) for heart failure

Uses a structured format?Background:YesObjectives:YesSearch strategy:YesSelection criteria:YesData collection and analysis: YesMain results:Pooled results reportedReviewers’ conclusions:Reports results IntroductionDetailed introduction that includes description of health problem, current treatment options and a brief overview of CRT Me...

Age of cardiac resynchronisation therapy; cardiac resynchronisation therapy in elderly

I have read the article entitled “Is cardiac resynchronisation therapy feasible, safe and beneficial in the very elderly?” by Olechowski, et al. with great interest, recently published in Journal of Geriatric Cardiology. The investigators reported that implantation of cardiac resynchronisation therapy (CRT) is feasible and safe in very elderly despite extensive co-morbidity. I would like to emp...

Cardiac resynchronisation improves survival in mild heart failure!

Several studies have already established the superiority of cardiac resynchronisation therapy (CRT)-defibrillator (D) over implantable cardioverter-defibrillator (ICD) alone in patients with severely symptomatic chronic heart failure (New York Heart Association (NYHA) class III/IV), left ventricular (LV) systolic dysfunction, and a wide QRS complex. Synchronous pacing of opposing LV walls in ma...